2013 Fiscal Year Final Research Report
Uterine leiomyoma and AMPK/mTOR signal transduction pathway- a new therapeutic strategy.
Project/Area Number |
23592430
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Obstetrics and gynecology
|
Research Institution | Kinki University (2012-2013) Tohoku University (2011) |
Principal Investigator |
TAKEDA Takashi 近畿大学, 東洋医学研究所, 教授 (20301260)
|
Co-Investigator(Kenkyū-buntansha) |
TSUIJI Kenji 東北大学, 大学院医学系研究科, 助教 (40528155)
LI Bin 東北大学, 大学院医学系研究科, 研究支援者 (20566814)
|
Project Period (FY) |
2011 – 2013
|
Keywords | 子宮筋腫 / mTOR / メトホルミン / 細胞増殖 / 血管新生 / VEGF / 分子標的 |
Research Abstract |
Metformin is an anti-diabetic drug that is used all over the world. We have proved its anti-tumor effect and anti-angiogenic effect through suppression of the mammalian target of rapamycin (mTOR) pathway.
|